(SAN FRANCISCO) Neuroscience Solutions (now renamed Posit Science Corporation), the foremost research and development company applying neuroplasticity technology to health concerns, and Scientific Learning Corporation (NASD: SCILE), the leading provider of neuroscience-based software products, announced they have completed a transaction that provides Neuroscience Solutions (now renamed Posit Science Corporation) exclusive rights in the healthcare field to certain intellectual properties, patents, and software held by Scientific Learning.
The transaction includes a sublicense of patents licensed by Scientific Learning from the University of California and Rutgers, the State University of New Jersey, as well as a transfer of certain healthcare research projects. The rights were acquired by Neuroscience Solutions for a combination of cash, stock, and future royalties. The two companies also have agreed to share certain additional technology as it is developed.
Neuroscience Solutions (now renamed Posit Science Corporation) plans to develop, market, and sell a series of software-based products for healthcare markets based on the latest research in neuroplasticity, the brain’s ability to change through experience, regardless of age.
Dr. Michael Merzenich, a co-founder of Neuroscience Solutions (now renamed Posit Science Corporation) and Scientific Learning and a member of the National Academy of Sciences, said:
“The neuroscience of brain plasticity strongly indicates the forms of special tools that should help remedy or ameliorate a wide variety of neurological and psychiatric problems. Scientific studies documenting the positive neurological impacts of the Fast ForWord family of products along with new, exciting findings in studies of aging have directed us to new strategies to overcome memory and cognitive loss, and to restore more normal posture, balance and mobility in older individuals . . . Neuroscience Solutions products should have a significant, positive impact on the quality of life of our aging population.”
Our goal is to help millions of aging individuals retain high mental and physical abilities to the end of life.